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Abstract
Background: Bowel symptoms are considered indicators of the presence of colorectal cancer and
other bowel diseases. Self administered questionnaires that elicit information about lower bowel
symptoms have not been assessed for reliability, although this has been done for upper bowel
symptoms. Our aim was to develop a self administered questionnaire for eliciting the presence,
nature and severity of lower bowel symptoms potentially related to colorectal cancer, and assess
its reliability.
Methods: Immediately before consulting a gastroenterologist or colorectal surgeon, 263 patients
likely to have a colonoscopy completed the questionnaire. Reliability was assessed in two ways: by
assessing agreement between patient responses and (a) responses given by the doctor at the
consultation; and (b) responses given by patients two weeks later.
Results: There was more than 75% agreement for 78% of the questions for the patient-doctor
comparison and for 92% of the questions for the patient-patient comparison. Agreement for the
length of time a symptom was present, its severity, duration, frequency of occurrence and whether
or not medical consultation had been sought, all had agreement of greater than 70%. Over all
questions, the chance corrected agreement for the patient-doctor comparison had a median kappa
of 65% (which represents substantial agreement), interquartile range 57–72%. The patient-patient
comparison also showed substantial agreement with a median kappa of 75%, interquartile range
68–81%.
Conclusion: This self administered questionnaire about lower bowel symptoms is a useful way of
eliciting details of bowel symptoms. It is a reliable instrument that is acceptable to patients and
easily completed. Its use could guide the clinical consultation, allowing a more efficient,
comprehensive and useful interaction, ensuring that all symptoms are assessed. It will also be a
useful tool in research studies on bowel symptoms and their predictive value for colorectal cancer
and other diseases. Studies assessing whether bowel symptoms predict the presence of colorectal
cancer should provide estimates of the reliability of the symptom elicitation.
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Background
Bowel symptoms are considered indicators of the pres-
ence of colorectal cancer and other bowel diseases. How-
ever, there is a dearth of reliable self administered
questionnaires that elicit information about lower bowel
symptoms.
Details of bowel symptoms are usually obtained from
patients as part of a face-to-face clinical consultation.
However, a self administered questionnaire may be an
efficient way of eliciting such information for clinical care
and screening programs. Self reported questionnaires
about bowel symptoms have been used successfully to
assess patients with upper gastrointestinal disease, to dis-
criminate between organic and functional bowel disease
and to assess faecal incontinence and constipation [1-8].
The reliability of some of these questionnaires has also
been assessed.
Questionnaires to assess lower bowel symptoms relevant
to colorectal cancer have also been developed. However,
the importance of symptoms is disputed. Some papers
suggest that specific symptoms may be useful to predict
colorectal cancer [9-16], while others have found no asso-
ciation for any symptoms [17-21]. One of the reasons for
this disparity in results may be the quality of symptom
elicitation; yet we could find little research assessing the
reliability of the questionnaire items used.
The aim of this study is to develop and assess the reliabil-
ity of an accessible and acceptable questionnaire about
bowel symptoms with particular relevance to colorectal
cancer, which can be used clinically and for research.
Methods
Questionnaire design
Content and face validity was achieved by basing the
questionnaire on literature review to determine question
content, with emphasis placed on symptoms that may
have predictive value for colorectal cancer, and on estab-
lished questionnaires [3,5,22,23]. Gastroenterologists
and colorectal surgeons were asked to comment on the
relevance and clarity of the questions, and an iterative
process with these specialists was undertaken to decide
which symptoms to include and how to word the ques-
tions.
Accessibility (understanding of the questions, and that the
questions ask what they purport to ask) was achieved by
interviewing 20 patients who completed the initial draft
of the questionnaire while waiting to see their gastroenter-
ologist or surgeon in consultation. Changes suggested by
this process were included in the questionnaire, and the
process repeated until no further problems were found.
Readability of the questionnaire was assessed from Micro-
soft Word 2003 using the Flesch reading score and the Fle-
sch-Kincaid reading level. The questionnaire has a Flesch-
Kincaid Reading Grade Level of 4.6 and a Flesch Reading
Ease score of 78.9. These scores are based on the average
number of syllables per word and words per sentence. The
Flesch-Kincaid Grade Level score rates text based on the
U.S. high school grade level system (i.e. a score of 4.0
would mean a 4th grader should be able to comprehend
the text). The Flesch Reading Ease score is based on a 100
point scale; the higher the score, the easier it is to compre-
hend. "Plain English" has a score of 65, which has an aver-
age sentence length of 15 to 20 words, and an average
word of two syllables [24].
The questionnaire we developed captures the information
about the presence or absence of symptoms, their charac-
teristics including severity, duration and timing, and
whether the symptom alone was regarded as serious
enough to prompt seeking medical advice. The questions
were presented in a flow diagram format, with connecting
arrows. The questionnaire was presented in a stapled
booklet format, and consisted of 10 pages of questions,
and a cover page for the participant's name and instruc-
tions for completing the questionnaire. There were 12
questions about bowel symptoms. These had an initial
question asking about the presence of the symptom. If the
symptom was present, the participant was directed to fur-
ther subquestions about detail of that symptom. An exam-
ple of a question is shown in Figure 1. The full
questionnaire is shown in the attached file [see Additional
file 1]. The questionnaire generally takes less than 15 min-
utes to complete.
Assessing agreement
The study was conducted with gastroenterologists and
colorectal surgeons at the Concord Repatriation General
Hospital, Sydney, Australia. The study was approved by
the University of Sydney and Central Sydney Area Health
Service (CRGH Zone) Ethics Committees.
Patients attending for consultation were invited to partic-
ipate. Those patients with predominantly lower gastroin-
testinal symptoms in the referral letter, who might
subsequently be advised to have a colonoscopy, were
included. Participants completed the questionnaire in the
waiting room immediately prior to their consultation
with the doctor. Exclusion criteria were patients younger
than 18 years, and insufficient English proficiency to com-
plete the questionnaire.
Although some may assess questionnaire validity by con-
sidering the doctors' responses to be the reference stand-
ard, such an approach assumes that the doctors are more
accurate than patients in determining symptoms. As thereBMC Gastroenterology 2008, 8:8 http://www.biomedcentral.com/1471-230X/8/8
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Example of a page from the questionnaire Figure 1
Example of a page from the questionnaire.
 2.   In the past few months, have you had pain in or around (outside) your back 
       passage (anus)? 
Go to question 3 
on next page 
Yes
No
I don't know 
Go to question 3 
on next page 
Yes
No
2e.   Have you been to see a doctor specifically
        about this pain in or around your back passage?    
Almost constantly
A few hours or less
A few minutes or less
2d.  In general, how long does this pain in or around your back passage last? 
2c.   In general, how bad is this pain/discomfort in or around your back passage? 
Daily
2 - 3 times a week
Weekly 
Monthly
Every few months
1 or 2 episodes only
2b.   On average, how often do you get this pain/discomfort
         in or around your back passage?       
2a.   How long ago did this pain or discomfort start? 
More than 2 years
1 - 2 years
1 - 12 months
2 - 4 weeks
Less than 2 weeks
Very mild (I can usually ignore the pain) 
Mild (I can ignore the pain if I don't think about it)
Moderate (I can't ignore the pain, but it does not stop me doing the things I usually do) 
Severe (The pain sometimes stops me doing the things I usually do)  
Very severe (The pain often stops me doing the things I usually do)BMC Gastroenterology 2008, 8:8 http://www.biomedcentral.com/1471-230X/8/8
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is little evidence for this assumption, our approach was to
assess the reliability of the questionnaire, which is a meas-
ure of the extent to which the same measurements of indi-
viduals obtained under different conditions yield similar
results [25]. We assessed two components of reliability:
reproducibility (the closeness of results obtained in the
same test material under a change of observer – inter-
observer comparison) by assessing agreement between
patients and doctors, and repeatability (the closeness of
results obtained in the same test material by the same
observer (intra-observer comparison) by assessing agree-
ment within patients.
The study therefore had two components: patient-doctor
agreement, and patient-patient agreement. Patient-doctor
agreement was assessed in one group of patients by com-
paring the results obtained from the questionnaire com-
pleted by the patient with those from a clinical interview
undertaken during the patient's usual consultation with
the specialist, immediately after the patient completed the
questionnaire. The specialist completed an identical ques-
tionnaire, blinded to the patient's response to the self-
administered questionnaire.
Patient-patient agreement was assessed in a separate,
independent group of patients by comparing the results
obtained from the self-administered patient question-
naire completed immediately prior to their consultation
with the doctor with those from a second identical ques-
tionnaire which was mailed to participants. In the second
questionnaire, patients were asked to answer the ques-
tions as they remembered their symptoms when they saw
their doctor. Where participants did not return the ques-
tionnaire, another questionnaire was mailed to them a
few weeks later. No incentives were offered for participa-
tion.
Testing took place in two phases. Following an initial
phase, minor changes were made to the questionnaire.
These changes were mainly changing free text answers to
tick box responses (based on the answers obtained in the
free text form in the initial questionnaire), or to the word-
ing of the options given. For questions that were changed,
results are reported only from the second testing phase.
Where questions were unchanged between the two ques-
tionnaires, the results are reported from both phases.
Statistical Analysis
Analysis was done using SAS (version 8.02) software. The
proportion of responses showing absolute agreement was
calculated. The kappa statistic (κ), a measure of agreement
that represents the proportion of agreement beyond that
expected by chance alone, was also calculated. κ can range
between 1 (perfect agreement), and 0 (level of agreement
expected by chance alone); κ > 0.80 is considered to reflect
almost perfect agreement, κ between 0.61 and 0.80 sub-
stantial agreement, 0.41–0.60 moderate agreement,
0.21–0.40 fair agreement, and κ < 0.20 poor agreement
[26]. Where the responses to the questions were ordinal, a
weighted kappa, using linear weights, has been used.
When assessing agreement for subquestions that were
asked if a particular symptom was reported, a category of
"symptom not reported" was included in the analysis.
Hence, all participants were included to take account of
disagreements in the reporting of the presence of the
symptom.
McNemar's test has been used to assess whether, for disa-
greements, there was evidence of a systematic direction for
the disagreements. For the patient-doctor study, this
assessed whether responses were more commonly
reported by patients or by doctors, and for the patient-
patient component, this assessed whether responses were
more commonly reported on the first or second occasion.
Results
A total of 263 participants completed the questionnaire
(patient-doctor study: n = 122; patient-patient study: n =
141) (see Table 1). For the patient-patient agreement
study, there was an 88% response rate for return of the
second questionnaire. The second questionnaire was
completed an average of 4.2 weeks after the first.
Patient-Doctor Agreement Study
There were 7 participating specialists: 3 gastroenterolo-
gists saw 74 (61%) patients, and 4 colorectal surgeons saw
48 (39%) patients. A total of 122 patients participated.
The age range of participants was 21 to 83 years (mean
age, 53 years); 58% were male. Thirty percent had a terti-
ary education (university degree), and a further 20% had
a diploma or trade qualification.
Bleeding per rectum, abdominal pain and change in
bowel habit were the most frequently reported symptoms
(see Table 2). Patients reported up to 12 (range 0 to12)
symptoms each (average 9.3, median 5), and doctors
reported up to 11 (range 0 to11) symptoms (average 8.5,
median 4) per patient.
Table 1: Study description and numbers participating
Patient-Doctor 
Agreement (n)
Patient-Patient 
Agreement (n)
Phase 1: 61 68
Changes made to some questions
Phase 2: 61 73
Total 122 141BMC Gastroenterology 2008, 8:8 http://www.biomedcentral.com/1471-230X/8/8
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Comparison of the patient-completed and doctor-com-
pleted responses show that in 78% of all questions there
was more than 75% agreement (agreement range
65%–96%, median 81%, interquartile range 75–89%).
Eight percent (8%) of questions had a κ > 80%, indicating
perfect agreement; 58% had a κ between 61 and 80%,
indicating substantial agreement; 30% had a κ between
41 and 60%, indicating moderate agreement only 4% (2
questions) had a κ < 40%, indicating fair agreement. The
median κ overall was 65% (range 34–89%; interquartile
range 57–72%).
Questions were grouped and analysed according to the
detail they elicited about the symptom (Table 3). The
main question (which elicited information about the
presence of a symptom) had a median κ of 59% (inter-
quartile range 57% to 68%) and median agreement of
88% (interquartile range 83%–91%). The duration of
symptoms had a median κ of 61% (interquartile range
59% to 64%) and median agreement of 78% (interquar-
tile range 75% to 80%), and the frequency of occurrence
had a median κ of 70% (interquartile range 52% to 73%)
and median agreement of 75% (interquartile range 74%
Table 3: Agreement and κ(%) between question detail categories: Patient- Doctor comparison
Presence Time since original onset Severe enough to 
prompt consultation
n Agree (%) κ(%) n Agree(%) κ(%) n Agree (%) κ(%)
PR bleeding 121 94 89 60 73 73 118 89 86
Abdominal pain 117 89 78 57 74 61 110 86 76
CBH 120 77 55 57 70 65 111 77 63
Fatigue 114 84 68 57 75 71 102 83 66
Urgency 1 0 5 8 05 8 5 1 7 8 7 0 9 9 7 25 1
Incomplete Evacuation 109 74 59 58 79 60 102 74 46
Anal pain 57 84 58 57 77 45 55 78 50
Weight loss 115 90 68 58 91 67 112 94 75
Anal lump 117 87 57 58 86 61 116 88 55
Mucus 120 90 64 58 90 69 118 90 55
Abdominal lump 119 94 44 58 95 65 118 96 37
Median 88 59 79 66 86 55
Note: n refers to the total number of patients and doctors answering this question (for the time since onset, the results are based only on the 
second phase questionnaire). CBH = Change in bowel habit
Table 2: Symptom: frequency (ranked by proportion of patients with the symptom in the patient-doctor agreement study)
Patient-Doctor Study Patient-Patient Study
Patient Doctor Patient (first questionnaire)
Symptom present % Symptom present % Symptom present %
PR Bleeding 55 45 54 44 53 38
Abdominal pain 53 45 48 40 69 50
Change Bowel Habit 52 43 50 41 65 46
Fatigue 39 34 39 32 47 34
Urgency 45 41 37 32 50 37
Incomplete Evacuation 42 38 32 27 60 44
Anal pain* 15 26 13 21 19 26
Weight loss 18 16 21 17 21 15
Anal lump 23 20 14 11 17 12
Mucus 14 12 18 15 21 15
Anaemia 9876 1 7 1 2
Abdominal lump 7632 6 4
Notes: For the patient-doctor agreement study, n = 122 except for missing responses (maximum 8) or where indicated by asterisk; for patient-
patient study n = 141, except for missing responses (maximum 7) or where indicated by asterisk.
*for the patient-doctor study: n = 61 (based only on the second phase questionnaire) except for missing responses (maximum 4); for patient-patient 
study, n = 73 (based only on the second phase questionnaire) except for missing responses (maximum 1)BMC Gastroenterology 2008, 8:8 http://www.biomedcentral.com/1471-230X/8/8
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to 76%). Compared to other symptom detail, severity of a
symptom had the highest median κ of 73% (interquartile
range 72%–74%), and median agreement of 77% (inter-
quartile range 77% to 78%). Information about other
symptom detail is given in Table 3.
When assessing disagreement between the patient and
doctor responses, only 4 (out of total of 50 questions)
showed evidence of a systematic difference (p < 0.05). Of
these, two questions showed a higher response from doc-
tors than patients: 9% more for whether an anal lump was
severe enough to prompt consultation (p = 0.01) 12%
more for whether or not urgency was severe enough to
prompt consultation (p = 0.02). Two questions showed a
higher response from patients than doctors: 10% more for
how long anal lump had been present (p = 0.03) and 7%
more for the presence of mucus (p = 0.02).
Patient-Patient Agreement Study
Patients were recruited from 9 participating specialists,
with 49% of patients attending gastroenterologists and
51% attending colorectal surgeons. A total of 141 patients
participated. The age range of patients was 24 to 87 years
(mean age of 59 years); 55% percent of the participants
were male. Thirty three percent had a tertiary education
(university degree), and a further 16% having a diploma
or trade qualification.
Abdominal pain, change in bowel habits and a feeling of
incomplete evacuation were the symptoms most com-
monly reported by patients. Rectal bleeding was the
fourth most common symptom (Table 2). Patients
reported up to 13 (range 0 to 13) symptoms each (average
of 11.2 symptoms, median 5) in the first questionnaire,
and up to 12 (range 0 to12) symptoms (average 9 symp-
toms, median 4) in the second questionnaire.
Comparison of the first and second patient responses
showed that in 92% of questions there was more than
75% agreement (agreement range 68%–99%, median
86%, interquartile range 81–92%). Thirty four percent
(34%) of questions had a κ > 80%, indicating perfect
agreement; 52% had a κ between 61 and 80%, indicating
substantial agreement; 30% had a κ between 41 and 60%,
indicating moderate agreement; 12% had a κ between 21
and 40%, indicating fair agreement only 2% (1 questions)
had a κ < 20%, indicating poor agreement.
Questions were grouped and analysed according to the
detail they elicited about the symptoms (Table 4). The
main question (which elicited information about the
presence of a symptom) had a median κ of 72% (inter-
quartile range 65 to 78%) and median agreement of 90%
(interquartile range 84 to 93%). The duration of symp-
toms had a median κ of 77% (interquartile range 75 to
79%) and median agreement of 84% (interquartile range
81 to 86%), frequency of occurrence had a median κ of
81% (interquartile range 80 to 83%) and median agree-
ment of 83% (interquartile range 79 to 83%), and severity
of a symptom had a median κ of 71% (interquartile range
65 to 78%), and median agreement of 87% (interquartile
range 83 to 91%). Information about other symptom
detail is given in Table 4.
When assessing disagreement between the first and sec-
ond patient responses, only 3 (out of total of 50 ques-
tions) showed evidence of a systematic difference (p <
0.05). Of these, 2 questions showed a higher response in
Table 4: Agreement and κ(%) between question detail categories: Patient- Patient comparison
Presence Time since original onset Severe enough to 
prompt consultation
nA g r e e  ( % ) κ(%) n Agree (%) κ(%) n Agree (%) κ(%)
PR bleeding 139 93 86 69 86 91 138 91 87
Abdominal pain 136 88 75 69 75 72 134 81 71
CBH 140 84 69 71 73 72 139 75 64
Fatigue 134 82 63 68 87 74 127 83 69
Urgency 130 83 65 69 78 79 125 78 66
Incomplete Evacuation 135 84 70 72 75 75 132 82 72
Anal pain 71 94 87 71 83 80 71 90 80
Weight loss 135 96 86 70 93 88 133 94 80
Anal lump 135 89 58 69 94 77 135 89 58
Mucus 138 93 74 72 99 87 134 94 76
Abdominal lump 135 92 42 69 91 46 134 94 18
Median 90 72 86 94 90 71
Note: n refers to the total number of patients answering this question.
CBH = Change in bowel habitBMC Gastroenterology 2008, 8:8 http://www.biomedcentral.com/1471-230X/8/8
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the first questionnaire: 7% more for the presence of
abdominal pain (p = 0.03) and 4% more for whether the
pain woke the patient at night (p = 0.04). By contrast, in
their second questionnaire, 13% more of patients
reported a longer time that a change in bowel habit had
been present (p = 0.04).
Comparison of agreement between patient-doctor and 
patient-patient completed questionnaires
The kappa values for patient-patient agreement were con-
sistently higher than those for patient-doctor agreement
(Table 4). This is shown graphically in Figure 2 for the
main questions (presence of symptoms). The patient-
patient kappa values and agreement are also higher than
the patient-doctor values for the questions relating to time
since onset of the symptom, its frequency, severity and
whether it was considered severe enough to prompt med-
ical consultation.
Discussion
A questionnaire should meet several criteria: it must elicit
information of relevance (content validity); the questions
must ask what they purport to ask (face validity); it must
be accessible; and information obtained must show good
agreement between patient and doctor and within
patients (patient-patient). Our questionnaire meets these
criteria. Compared to general medical history taking and
clinical examination, the kappa values and agreement are
good [26]. They are similar to those reported for question-
naires applied to upper gastrointestinal disease or faecal
incontinence [2,3,5,7,8,22,23].
Our questionnaire was completed by the patient in the
waiting room immediately prior to their consultation
with the specialist. It might be argued that, at that time,
patients are more focussed on their symptoms or are dis-
tracted by the imminent consultation. Nevertheless, there
is good agreement between the questionnaires completed
in the waiting room and those completed several weeks
later, so that the timing of administration of the question-
naire does not seem to be an important issue.
Bowel symptom history is usually taken by medical prac-
titioners as part of a face-to-face consultation. We have
used the data from the physician interview to assess agree-
ment between this clinical history with that obtained
from the patient. However, there is no research to show
that the data from the physician's history of symptoms is
more accurate than that obtained from patients. Indeed, it
has also been shown that patients and doctors may have
different perceptions of health problems, and of the
importance of these [27]. Health questionnaires com-
pleted by patients frequently capture more positive symp-
toms than are elicited by doctors during consultation [28-
30]. This is the case with our questionnaire, with patients
reporting on average 1 more symptom than elicited by the
specialists.
People presenting with bowel symptoms are often inves-
tigated with colonoscopy. There is little high quality evi-
dence to show which symptoms, if any apart from
bleeding, improve the diagnostic yield of cancers or pre-
cancerous polyps. While some papers suggest that symp-
toms may be useful to predict colorectal cancer [9-14],
others have found no association [17-21]. One recent
study in the UK has suggested that a questionnaire can be
used to elicit symptoms, and that these symptoms, com-
bined with a weighted numerical score, can be used to
predict colorectal cancer [15], and that this combination
of symptoms performs better than other symptom groups
proposed in cancer referral guidelines [16]. On the other
hand, a large study in the USA has found that people with
and without bowel symptoms show no difference in rates
of colorectal cancer or polyps [31]. With the current drive
towards public education about colorectal cancer symp-
toms it is likely that that many more individuals with
minimal symptoms might present for colonoscopy. The
costs, both clinical and financial, of performing colono-
Scatterplot: Kappa agreement: presence of symptom Figure 2
Scatterplot: Kappa agreement: presence of symp-
tom. Note: the numbers in the plot refer to the question 
number. 1 = abdominal pain; 2 = anal pain; 3 = change in 
bowel habit; 4 = urgency; 5 = incomplete evacuation;; 6 = 
rectal mucus; 7 = rectal bleeding; 8 = fatigue; 9 = weight loss; 
10 = abdominal lump; 11 = anal lump; 12 = anaemia.
1
2
3
4
5
6
7
8
9
10
11
12
0
20
40
60
80
100
02 0 406 08 0 100
patient-doctor
p
a
t
i
e
n
t
-
p
a
t
e
i
n
tBMC Gastroenterology 2008, 8:8 http://www.biomedcentral.com/1471-230X/8/8
Page 8 of 9
(page number not for citation purposes)
scopies and the implications for health service provision,
both at individual and community levels, are therefore
high. It is thus important to assess which symptoms pre-
dict and which do not predict the presence of cancer, and
an easily applied self administered questionnaire may
provide a tool for use in this assessment.
Results in studies about the predictive value of symptoms
may differ because of the quality of symptom elicitation.
If symptom elicitation is inaccurate or incomplete, the
predictive value of the symptoms will be diminished. Mis-
classification in symptom elicitation between studies may
therefore account for the differing study results. To allow
adequate interpretation, studies of the predictive validity
of symptoms should include estimates of the reliability of
the questionnaire, using methods like we have presented.
Conclusion
Our study shows that this questionnaire is reliable means
of assessing bowel symptoms, and is acceptable to
patients. Potential application of the questionnaire
includes use as part of the clinical consultation to enhance
the consultation and to ensure that all patient symptoms
are assessed. One of the strengths of this study is the
assessment of the agreement between patients and their
doctors. This agreement was good. On average, patients
reported one more symptom than reported by the doctor.
Use of the questionnaire could therefore facilitate discus-
sion of all patient symptom concerns. Its use could guide
the consultation, allowing a more efficient, comprehen-
sive and useful interaction. It may also have use for
research, for example to assess the significance and predic-
tive value of symptoms for colorectal cancer, and as part
of a bowel cancer screening program to elicit symptoms of
potential significance. The questionnaire can be used as a
reliable standardised instrument in studies to assess the
predictive validity of symptoms for colorectal cancer.
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